National, clinical cohort study of late effects among survivors of acute lymphoblastic leukaemia: the ALL-STAR study protocol

INTRODUCTION: More than 90% of patients diagnosed with childhood acute lymphoblastic leukaemia (ALL) today will survive. However, half of the survivors are expected to experience therapy-related chronic or late occurring adverse effects, reducing quality of life. Insight into underlying risk traject...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:BMJ Open
Autors principals: Andrés-Jensen, Liv, Skipper, Mette Tiedemann, Mielke Christensen, Kristian, Hedegaard Johnsen, Pia, Aagaard Myhr, Katrine, Kaj Fridh, Martin, Grell, Kathrine, Pedersen, A. M. L., Leisgaard Mørck Rubak, Sune, Ballegaard, Martin, Hørlyck, Arne, Beck Jensen, Rikke, Lambine, Trine-Lise, Gjerum Nielsen, Kim, Tuckuviene, Ruta, Skov Wehner, Peder, Klug Albertsen, Birgitte, Schmiegelow, Kjeld, Frandsen, Thomas Leth
Format: Artigo
Idioma:Inglês
Publicat: BMJ Publishing Group 2021
Matèries:
Haematology (Incl Blood Transfusion)
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7875271/
https://ncbi.nlm.nih.gov/pubmed/33563628
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2020-045543
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars